Sotagliflozin Lowers A1c, Weight Even in Kidney Impairment
"These findings highlight the importance of considering the effect of kidney function to help inform and tailor treatment decision-making for patients with diabetes and CKD," Belinda Hardin, PharmD, senior director of medical communications and head of field medical at Lexicon, said at the American Association of Clinical Endocrinology (AACE) Annual Meeting 2025.
Sotagliflozin, a novel agent that inhibits sodium-glucose cotransporter (SGLT) 1 as well as SGLT2, was approved by the US Food and Drug Administration (FDA) in 2023 for reducing the risks of cardiovascular death, hospitalization for heart failure, and urgent heart failure visits in patients with heart failure, and for preventing these same events in patients with type 2 diabetes, CKD, and other cardiovascular disease risk factors.
The drug is not indicated for diabetes. In 2019, the FDA declined to approve sotagliflozin as adjunctive treatment for type 1 diabetes due to concerns about the increased risk for diabetic ketoacidosis. And in 2024, the agency again turned down Lexicon's application for sotagliflozin as a treatment for people with type 1 diabetes and CKD. The company hasn't sought an indication for sotagliflozin for type 2 diabetes.
Two SGLT2 inhibitors, dapagliflozin (Farxiga) and empagliflozin (Jardiance), have indications for preventing heart failure hospitalizations in patients with heart failure as well as approvals for type 2 diabetes and preservation of renal function.
The new findings, from a meta-analysis of eight double-blind, randomized, placebo-controlled trials, suggest that despite the lack of an indication for treatment of diabetes or obesity, sotagliflozin does result in A1c and body weight lowering across all levels of kidney function. This study is a companion to a previous similarly designed analysis showing that the effects of sotagliflozin on systolic blood pressure were maintained in patients with type 2 diabetes regardless of kidney function. Those findings were presented at the American Heart Association Scientific Session 2024, Hardin told Medscape Medical News .
Asked for comment, session moderator Sara E. Lubitz, MD, associate professor of medicine and endocrine program director at Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, told Medscape Medical News : "This opens my mind more that if there is a heart failure patient with diabetes and we're looking for sugar reduction as well as heart failure protection, [sotagliflozin] is probably just as efficacious as the SGLT2 inhibitors...that have the indication for glucose-lowering, but we're not pulling it out as a first-line [treatment]."
All eight trials in the meta-analysis had similar designs and timeframes and were at least 26 weeks in duration. The patient-level intent-to-treat population data were pooled. Patients were divided into three subgroups based on kidney function:
Subgroup 1: estimated glomerular filtration rate (eGFR) ≥ 60 mL/min/1.73m 2 (N = 2577)
(N = 2577) Subgroup 2: eGFR ≥ 30 to < 60 mL/min/1.73m 2 (N = 1046)
(N = 1046) Subgroup 3: eGFR < 30 mL/min/1.73m2 (N = 271)
Mean patient ages were 60.2 years in subgroup 1, versus 69.3 and 67.1 years, respectively, in subgroups 2 and 3. The treatment groups were sotagliflozin 400 mg (N = 1728), sotagliflozin 200 mg (N = 728), or placebo (N = 1440).
Overall, compared with placebo, A1c was significantly lowered with 200-mg sotagliflozin (less mean squares [LMS] difference, –0.33) and 400 mg (LMS difference, –0.48). Body weight was also reduced (LMS difference, –1.48 and –1.66, respectively).
The effects on both A1c and body weight of both doses were statistically significant for the overall study population and subgroup 1 (normal kidney function). In subgroup 2, the effect on body weight remained significant for both doses, but only the 400-mg dose effect was significant for lowering A1c.
The 400-mg dose produced significant reductions in all kidney function subgroups for both measures except A1c reduction in subgroup 3, although there was still benefit.
Hardin told Medscape Medical News , "This provides us supplemental information with regard to heart failure outcomes, and not directly focusing on whether there's an additive benefit in terms of A1c or an additive lowering of A1c in patients with chronic kidney disease."
Asked about future plans for sotagliflozin, she replied, "I don't think at this point you'll likely see sotagliflozin before the FDA for a glucose-lowering indication in type 2 patients. The file remains open for type 1 at the FDA, so that work continues."
Hardin is an employee of Lexicon. Lubitz is a speaker for Ascendis and has received clinical trial research funding from Ascendis, Chiasma, and Takeda.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Forbes
9 minutes ago
- Forbes
Who Are Those Fantastic SuperAgers And Why Do They Stay Healthy?
Everyone wants to stay fully independent as we age. A few people over age 80 do and they don't suffer from memory loss either. They are called 'super agers' because they do not suffer the same mental and physical declines as almost everyone else. They've been studied by researchers for decades. We do have some answers to what makes them different from everyone else. Maybe we all wish we could be super agers ourselves. What Is A Super Ager? The term describes someone over 80 with an exceptional memory — one at least as good as the memories of people who are 20 to 30 years younger. They don't get Alzheimer's disease. They think clearly and participate in many things most folks their age cannot do. As reported in AARP, those who seem to defy normal changes of aging have a few things in common. Here are some of these, also reflected in research from other reports in other places in the U.S. 1. Thicker brains We don't know if it's a hereditary thing or not but with this rare group, the part of the brain which impacts thinking, memory and decision-making is thicker in super agers — sometimes thicker even than it is in most people in their 50s and 60s. It resists shrinking. 2. Supersize memory cells in their brains. These larger than average sized particular nerve cells resist the protein deposits associated with cognitive decline and Alzheimer's disease. The protein plaques and tangles may be present in the brains of those super agers, seen from those who donated their brains to studies after they pass, but they do not seem to cause damage. 3. More 'social intelligence' brain cells These particular kinds of brain cell cells have been linked to social intelligence and awareness. They help facilitate rapid communication across the brain, providing an enhanced ability to navigate the outside impacts thinking, memory and decision-making. As I see it, that would suggest greater levels of independence in aging, an elusive thing most want but few over 80 actually achieve. What If You Aren't Born With That Kind Of Brain? There is plenty of research on preventing dementia to tell us that lifestyle is perhaps the most important feature of aging well, whether you are destined to be a super ager or not. Most of the super agers are very active and maintain healthy habits. One of my favorite examples is the late Dr. Ruth Westheimer, the famous sex therapist. She was a TV personality, author of numerous books and, as she used to say, a nonstop talker. Her belief was that talking exercises the brain. OK, we know some nonstop talkers who are definitely not exercising their brains so that's not all there is to keeping one's brain active. But being silent and withdrawn is certainly not helpful lifestyle clearly includes regular exercise, even walking. It doesn't take running marathons. And food choices are part of this, of course as well. Data more recently shows a link between consuming ultra processed foods (sweets, packaged snacks, etc.) and cognitive decline. The better choices, as we are often told, include fish, vegetables, fruits and whole grains, avoiding junk food and excess. Other resources emphasize the importance of social connections in aging to help ward off dementia, getting enough sleep, and managing stress. Easier said than done! And one thing the super agers who have been studied also have in common is the unwavering willingness or ability to constantly challenge themselves. The Takeaway Not everyone will have a super ager's remarkably different kind of brain structure. But everyone can see their good health habits and aim for doing what they do. They stay active in many ways, socially engaged, and everyone can make that an achievable goal.
CBS News
9 minutes ago
- CBS News
After CDC shooting, leadership vacuums and delays frustrate staff
Four days after a gunman riddled the Centers for Disease Control and Prevention's main campus in Atlanta with bullets, CDC employees say they are still looking for steady leadership and clear communication. The agency's first all-hands meeting since the attack ran roughly 12 minutes, began late and was beset by technical problems, according to staff who tried to watch. In Tuesday's all-hands, new CDC Director Susan Monarez described the shooting as "an attack in our community … and in many ways the very mission that we serve." She warned that "misinformation can be dangerous … we need to rebuild the trust together," urging "rational, evidence-based discourse … with compassion and understanding." CDC security chief Jeff Williams told staff investigators view the incident as "a targeted attack on the CDC related to COVID-19." He said agency security "stopped" an intrusion that could have resulted in many more casualties, that nearly 100 children at the childcare center were reunited with parents that night, and that investigators recovered nearly 500 shell casings. More than 180 rounds struck six buildings, leaving extensive damage that will take time to repair. Monarez closed the meeting by honoring fallen DeKalb County Police Officer David Rose and pointing staff to a CDC Foundation fund for his family. In April, more than 200 staff were fired from the CDC's Injury Prevention Center. In the aftermath of Friday's shooting, several CDC employees noted the grim irony: the team charged with studying how to prevent firearm violence had been dismissed. One employee who spoke with CBS News on background, because they were not authorized to comment publicly, described Monarez's remarks as "heavily scripted." Another staffer said, "Monarez is new and doesn't know the agency, but she could have brought in career leaders … to show that she's working hand in hand with experienced CDC leaders. It feels like most of the CDC community is really trying to unify and support each other." A union message referred to the meeting, which lasted from 11:12 a.m. to 11:24 a.m., as "insultingly insufficient," and invited workers to a noon healing session. "Dr. Monarez and CDC leadership remain focused on supporting staff during an extraordinarily difficult time as evidenced by their continued direct engagement," Andrew Nixon, a spokesman for the Department of Health and Human Services, told CBS News. "Friday's shooting was a traumatic event for the agency, and leadership is working to provide continued updates along with resources for healing and recovery. There will be continued opportunities for staff engagement and dialogue in the days ahead." Several employees praised separate Saturday and Tuesday calls for the CDC's National Center for Immunization and Respiratory Diseases, led by Dr. Demetre Daskalakis, describing them as "validating," with clear next steps and mental-health resources. Monarez joined the Saturday call and "was more natural and less scripted," a staffer said. On Tuesday, Daskalakis told staff, "We've experienced a horrific and intentionally targeted attack … we're shocked, we're grieving, we're scared," and he urged teams to use the space to speak frankly. He emphasized that CDC would take "time and space before we come back," noting the investigation is "complex and ongoing." The meeting centered on mental health and resources to support traumatized staffers. Daskalakis introduced Dr. David Schonfeld of the National Center for School Crisis and Bereavement at the Children's Hospital Los Angeles, who walked through common post-crisis reactions. "Most people try and hide their distress," he said, encouraging employees to seek support rather than suppress their feelings. Trying to do so, he added, "is not a superpower." Daskalakis noted reports that the suspect was angry about COVID-19 vaccines and influenced by conspiracy theories. "This is not our fault," he said. "Our work is love and what we experienced is hate." Many of the CDC's centers are currently led by acting directors, after several center directors were reassigned to the Indian Health Service earlier this year. Health and Human Services Secretary Robert F. Kennedy Jr. visited the CDC's campus on Monday, three days after the attack, while most staff were instructed by leadership to telework due to safety concerns and the ongoing assessments following the shootings. On the same day that he visited the CDC, Kennedy gave an interview to Scripps News in which he once again raised questions about vaccine safety, drawing sharp criticism from some CDC staff, who argued that anti-vaccine rhetoric, including from Kennedy, helped create the conditions for the attack. HHS spokesman Andrew Nixon told CBS News, "This is a time to stand in solidarity with our public health workforce and we hope the media will respect the moment rather than exploiting a tragedy and further exacerbating an already harrowing experience by the dedicated CDC staff." White House spokesman Kush Desai said, "Violence has no place in any civil society, and the White House extends our heartfelt condolences to the family of Officer David Rose and the entire CDC team."
CBS News
9 minutes ago
- CBS News
California could save $225 million yearly by ditching return-to-office mandate, audit Finds
A new audit found that the State of California could save $225 million a year by not enforcing return-to-office orders for state workers. The audit comes amid the saga for state workers and the political debate between remote versus in-person work. It found that Gov. Gavin Newsom's office "did not gather some important information about space needs and costs" before ordering employees back to the office four days a week. Assemblymember Josh Hoover requested the audit and said the findings dispute Newsom's calls for a one-size-fits-all hybrid work order. "One of the big problems is that the governor's office was not prepared for a return-to-work order," Hoover said. "I really don't think this should be a partisan issue. I think we should be doing what makes the most sense from a policy standpoint." The audit also showed that some state departments don't have the space for all their employees to return to the office four days a week after ending office leases during the pandemic. The audit shows the Department of Health Care Services would need 541 more workspaces, and the Department of Resources, Recycling and Recovery needs 123 more workspaces. "He told state agencies you need to prepare for telework and implement telework, and that led to decisions where in some cases they're not set up to get employees back," Hoover said. Newsom's office issued a response disagreeing with the study, saying: "This audit on state telework is not a scientific study, nor does it paint a complete picture of the state workforce or the benefits of working in person. While we appreciate the auditor's time in collecting this information, we respectfully disagree with the auditor's findings, which are based on estimates and, as noted throughout the audit, hypothetical theories and incomplete information. However, we will take their recommendations into account as we move forward with managing the state workforce and facilities." State worker unions have protested the governor's four-day return to office orders, which are currently set to take effect in July 2026. Now, this audit is adding to the dispute. "For me, it has been a reminder that we cannot rest," Neto said. The audit recommends that the state legislature jump into this debate and create laws requiring every state department to decide which positions should be remote and in person. Assemblymember Hoover said that he hopes to introduce that legislation next year.
